NantHealth, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NHIQ research report →
Companynanthealth.com
NantHealth, Inc. , together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions.
- CEO
- Rao Haris Naseem FACC,
- IPO
- 2016
- Employees
- 365
- HQ
- Morrisville, NC, US
Price Chart
Valuation
- Market Cap
- $329.66K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -6.90
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 56.96%
- Op Margin
- -76.61%
- Net Margin
- -101.16%
- ROE
- 34.99%
- ROIC
- -40.36%
Growth & Income
- Revenue
- $67.00M · 6.95%
- Net Income
- $-67,779,000 · -16.34%
- EPS
- $-8.80 · -14.88%
- Op Income
- $-51,327,000
- FCF YoY
- -18.20%
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.00
- Beta
- -5.74
- Avg Volume
- 263
Get TickerSpark's AI analysis on NHIQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NHIQ Coverage
We haven't published any research on NHIQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NHIQ Report →